Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

ASTRAZENECA : UBS drops its Sell rating

11/30/2020 | 06:53am EST

UBS is out with its report today upgrading ASTRAZENECA from Sell to Neutral. Previously set at GBX 7300, the target price has been slightly modified to GBX 7500.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.78% 7722 Delayed Quote.4.62%
UBS GROUP AG -1.45% 13.22 Delayed Quote.7.58%
All news about ASTRAZENECA PLC
01:57pPeru says Sinopharm, Pfizer seek approval for their COVID-19 vaccines
RE
01:43pASTRAZENECA : India to start COVID vaccine exports on Wednesday
RE
01:37pASTRAZENECA : India to start COVID vaccine exports on Wednesday
RE
11:35aBrussels targets vaccinating at least 70% of EU adults by summer
RE
07:45aASTRAZENECA : India's homegrown vaccine developer warns some to avoid shot
AQ
07:31aJapan has pre-ordered COVID-19 vaccine doses for more than four times its pop..
AQ
06:44aSputnik-AstraZeneca vaccine trials to start in February, says R-Pharm
RE
06:38aPhilippines to buy 20 million Moderna vaccine doses as COVID-19 cases rise
RE
05:00aASTRAZENECA : Thailand defends royal company's role in vaccine strategy
RE
04:39aASTRAZENECA : Thailand defends royal company's role in vaccine strategy
RE
More news
Financials (USD)
Sales 2020 26 399 M - -
Net income 2020 2 970 M - -
Net Debt 2020 13 223 M - -
P/E ratio 2020 30,3x
Yield 2020 3,65%
Capitalization 101 B 137 B -
EV / Sales 2020 4,31x
EV / Sales 2021 3,72x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 126,16 $
Last Close Price 77,22 $
Spread / Highest target 102%
Spread / Average Target 63,4%
Spread / Lowest Target 8,90%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC4.62%136 529
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG1.93%303 276
NOVARTIS AG1.65%217 178
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993